Ovarian Sertoli-Leydig cell tumor, endometrioid-like yolk sac tumor, and Y-chromosomal material

Oncology

Volumn 64, Issue 4, 2003, Pages 370-373

  De Giorgi, Ugo ^a   Turci, Daniele ^a   Crisanti, Emilia ^a   Cantù, Maria Grazia ^b   Cappellini, Anna ^b   Marangolo, Maurizio ^a  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Ovarian cancer; Sertoli Leydig cell tumor; Y chromosomal material; Yolk sac tumor

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; MITOMYCIN C; PACLITAXEL; TOPOTECAN;

ADULT; ANDROBLASTOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER FAMILY; CANCER MORTALITY; CASE REPORT; CHROMOSOME 1; CHROMOSOME ANALYSIS; CHROMOSOME VARIANT; DIAGNOSTIC TEST; ENDOMETRIOID CARCINOMA; EVIDENCE BASED MEDICINE; FATHER; FEMALE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HUMAN TISSUE; KARYOTYPE; LABORATORY TEST; LIVER METASTASIS; MYOMETRIUM; OVARY METASTASIS; PATERNITY; PERITONEUM METASTASIS; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME; TUMOR GROWTH; Y CHROMOSOME; YOLK SAC TUMOR; GENETICS; OVARY TUMOR; PATHOLOGY; PEDIGREE;

ADULT; CHROMOSOMES, HUMAN, Y; ENDODERMAL SINUS TUMOR; FEMALE; HUMANS; OVARIAN NEOPLASMS; PEDIGREE; SERTOLI-LEYDIG CELL TUMOR;

EID: 0038312279     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070295     Document Type: Article

References (15)

1. Young RH, Scully RE: Ovarian Sertoli-Leydig cell tumours: A clinicopathological study of 207 cases. Am J Surg Pathol 1985;9:543-569.
2. Young RH: Sertoli-Leydig cell tumors of the ovary: Review with emphasis on historical aspects and unusual variants. Int J Gynecol Pathol 1993;12:141-147.
3. Motoyama I, Watanabe H, Gotoh A, Takeuchi S, Tanabe N, Nashimoto I: Ovarian Sertoli-Leydig cell tumor with elevated serum alpha-fetoprotein. Cancer 1989;63:2047-2053.
4. Clement PB, Young RH, Scully RE: Endometrioid-like variant of ovarian yolk sac tumour. A clinicopathologic analysis of eight cases. Am J Surg Pathol 1987;11:767-778.
5. Kommoss F, Schmidt M, Merz E, Knapstein PG, Young RH, Scully RE: Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years. Gynecol Oncol 1999;72:421-424.
6. Gravholt CH, Fedder J, Naeraa RW, Muller J: Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosomal material: A population study. J Clin Endocrinol Metab 2000;85:3199-3202.
7. Gibbons B, Tan SY, Yu CC, Cheah E, Tan HL: Risk of gonadoblastoma in female patients with Y chromosome abnormalities and dysgenetic gonads. J Paediatr Child Health 1999;35:210-213.
8. Muroya K, Ishii T, Nakahori Y, Asakura Y, Tachibana K, Masuno M, Imaizumi K, Tanaka Y, Kawada Y, Yukizane S, Ogata T: Gonadoblastoma, mixed germ cell tumor, and Y chromosomal genotype: Molecular analysis in four patients. Genes Chromosomes Cancer 1999;25:40-45.
9. Matloff ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN: What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination. J Clin Oncol 2000;18:2484-2492.
10. Emery J, Murphy M, Lucassen A: Hereditary cancer - The evidence for current recommended management. Lancet Oncol 2000, pp 9-16.
11. Olopade OI, Pichert G: Cancer genetics in oncology practice. Ann Oncol 2001;12:895-908.
12. NIH Consensus Development Panel on Ovarian Cancer: Ovarian Cancer: Screening, treatment and follow-up. JAMA 1995;273:491-497.
13. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K: Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2002;346:1609-1615.
14. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL: Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 2002;346:1616-1622.
15. Piver MS, Jishi MF, Tsukada Y, Nava G: Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer 1993;71:2751-2755.